ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
1. 1ÔÂ14ÈÕ£¬»ª¶«Ò½Ò©Ðû²¼È«×Ê×Ó¹«Ë¾º¼ÖÝÖÐÃÀ»ª¶«ÖÆÒ©ÓÐÏÞ¹«Ë¾ÊÕµ½ ÃÀ¹úFDA֪ͨÅú×¼HDM2006ƬҩƷÁÙ´²ÊÔÑéÉêÇ룬¿ÉÔÚÃÀ¹ú¿ªÕ¹IÆÚÁÙ´²ÊÔÑ飬˳Ӧ֢ΪÍíÆÚ¶ñÐÔÖ×Áö¡£HDM2006ƬÊÇÓÉÖÐÃÀ»ª¶«×ÔÖ÷Ñз¢µÄ°ÐÏòHPK1£¨Hematopoietic Progenitor Kinase-1£¬ÔìÑª×æ¼¤Ã¸ 1£©µÄÐÂÐÍ¡¢Ç¿Ð§¡¢¸ßÑ¡ÔñÐÔ¡¢ÊʿڷþÎüÊÕµÄÂѰ׽µ½â°ÐÏòǶºÏÌ壨PROTAC£©1À໯ѧҩƷ¡£
2. 1ÔÂ15ÈÕ£¬CDE¹ÙÍø¹«Ê¾£¬ÓÉÈüŵ·Æ£¨Sanofi£©É걨µÄ1ÀàÐÂÒ©itepekimab×¢ÉäÒº»ñÅúÁÙ´²£¬ÄâÊÊÓÃÓÚÖÎÁÆÂýÐÔ±Çñ¼Ñײ»°é±ÇÏ¢È⣨CRSsNP£©»¼Õß¡£ÕâÊÇÒ»¿î°ÐÏòIL33µÄµ¥¿Ë¡¿¹Ì壬ÓÉÈüŵ·ÆÓëÔÙÉúÔª£¨Regeneron£©ÏàÖú¿ª·¢¡£
3. 1ÔÂ14ÈÕ£¬¼Ã´¨Ò©ÒµÐû²¼Í¨¸æ³Æ£¬È«×Ê×Ó¹«Ë¾¼Ã´¨Ò©Òµ¼¯ÍÅÓÐÏÞ¹«Ë¾ÊÕµ½¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾ÖÅú׼ǩ·¢µÄÂÞɳ˾Ëû½ºÄÒ¡¶Ò©Æ·×¢²áÖ¤Êé¡·¡£¸Ã²úÆ·×¢²á·ÖÀàΪ»¯Ñ§Ò©Æ·4À࣬Ö÷ÒªÓÃÓÚÂýÐÔÉöÔಡ£¨CKD£©ÒýÆðµÄѪÐ飬°üÀ¨Í¸Îö¼°·Ç͸Îö»¼Õß¡£
4. 1ÔÂ14ÈÕ£¬ÖйúÉúÎïÖÆÒ©ÆìÏÂÕý´óÌìÇçÒ©Òµ¼¯ÍÅ×ÔÖ÷Ñз¢µÄJAK/ROCKÒÖÖÆ¼ÁTQ05105£¨ÂÞ·¥ÎôÌæÄᣩ¶þÆÚÐÂÒ©ÁÙ´²ÊÔÑéÉêÇ루IND£©»ñµÃÃÀ¹úʳÎïÒ©Æ·¼àÊÓÖÎÀí¾Ö£¨FDA£©Åú×¼£¬ÄâÓÃÓÚÖÎÁÆÂýÐÔÒÆÖ²ÎËÞÖ÷²¡£¨cGVHD£©¡£
1. 1ÔÂ13ÈÕ£¬¸´ºêººÁØÐû²¼ÓëAbbottÇ©ÊðÔÊÐíÐÒ飬ÊÚÓèÆäÔÚ69¸öÐÂÐËÊг¡¹ú¼ÒºÍµØÇø¶À¼Ò»ò°ë¶À¼Ò¿ª·¢ºÍÉÌÒµ»¯¹«Ë¾×ÔÖ÷¿ª·¢µÄËÄ¿îÉúÎïÀàËÆÒ©ºÍÒ»¿îÉúÎïÁ¢ÒìÒ©£¬ÐÒéÁýÕÖÑÇÖÞ¡¢À¶¡ÃÀÖ޺ͼÓÀձȺ£µØÇø¼°Öж«±±·Ç¡£¸ÃÔÊÐíÐÒéÊÇÔÚË«·½ÏÖÓÐÖ×ÁöÁìÓòÉúÎïÀàËÆÒ©ÏàÖúµÄ»ù´¡ÉϽøÒ»²½É¡£
1. 1ÔÂ14ÈÕ£¬Õã½´óѧÁõæÃ½ÌÊÚÍŶӡ¢·½¶«½ÌÊÚÍŶӼ°»Æ¿¡½ÌÊÚÍŶӣ¨²©Ê¿Éúлº£»ª¡¢ËÎÀñ־ΪÅäºÏµÚÒ»×÷Õߣ©ÏàÖú£¬ÔÚ Nature ×Ó¿¯ Nature Chemical Biology ÉϽÒÏþÁËÌâΪ£ºSynergistic protection of nascent DNA at stalled forks by MSANTD4 and BRCA1/2-RAD51 µÄÑо¿ÂÛÎÄ¡£¸ÃÑо¿Õ¹ÏÖÁËÒ»ÌõÓë BRCA1/2 ºÏ³ÉÖÂËÀµÄÐÂͨ·¡£
[1]Xie, H., Song, L., Mao, G. et al. Synergistic protection of nascent DNA at stalled forks by MSANTD4 and BRCA1/2¨CRAD51. Nat Chem Biol (2025). https://doi.org/10.1038/s41589-024-01833-9